Tag Archives: Michael Matson

LivaNova PLC (LIVN) Gets a Buy Rating from Needham

In a report released today, Michael Matson from Needham reiterated a Buy rating on LivaNova PLC (LIVN – Research Report), with a price target of $91. The company’s shares closed last Monday at $79.68. According to TipRanks.com, Matson is a

Medtronic (MDT) Gets a Buy Rating from Needham

In a report released today, Michael Matson from Needham reiterated a Buy rating on Medtronic (MDT – Research Report), with a price target of $133. The company’s shares closed last Monday at $107.54, close to its 52-week high of $109.70.

Needham Keeps a Hold Rating on NuVasive (NUVA)

In a report released today, Michael Matson from Needham maintained a Hold rating on NuVasive (NUVA – Research Report). The company’s shares opened today at $65.84. According to TipRanks.com, Matson is a 5-star analyst with an average return of 7.8%

Analysts Offer Insights on Healthcare Companies: Hill-Rom (NYSE: HRC) and Assembly Biosciences (NASDAQ: ASMB)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Hill-Rom (HRC – Research Report) and Assembly Biosciences (ASMB – Research Report) with bullish sentiments. Hill-Rom (HRC) Needham analyst Michael Matson reiterated

Analysts Conflicted on These Healthcare Names: SurModics (NASDAQ: SRDX) and Pfizer (NYSE: PFE)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on SurModics (SRDX – Research Report) and Pfizer (PFE – Research Report). SurModics (SRDX) In a report released today, Michael Matson from Needham maintained

Analysts Offer Insights on Healthcare Companies: Medtronic (NYSE: MDT) and Ellex Medical Lasers Limited (Other OTC: ELXMF)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medtronic (MDT – Research Report) and Ellex Medical Lasers Limited (ELXMF – Research Report) with bullish sentiments. Medtronic (MDT) Needham analyst Michael